Navigation Links
Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
Date:1/15/2009

TALLINN, Estonia, Jan. 15 /PRNewswire-FirstCall/ -- Cancer patients in Estonia now have access to advanced radiotherapy techniques, such as intensity modulated radiotherapy (IMRT), for the first time with the official unveiling shortly before Christmas of an advanced Varian Medical Systems treatment machine at the North Estonia Regional Hospital in the country's capital, Tallinn. The opening ceremony attracted publicity on Estonian national TV and in national newspapers.

North Estonia Regional Hospital, which serves two-thirds of Estonia's 1.4 million population, has doubled its linear accelerator capacity with the acquisition of a Varian Clinac(R) DHX equipped with a Millennium(TM) 120-leaf collimator, enabling more conformal radiotherapy treatment. "We have moved from conventional radiotherapy to conformal radiotherapy for the first time," says senior physicist Eduard Gerskevitch. "The collimator's finer leaves allow clinicians to conform the treatment beam tighter to the tumor and limit irradiation of normal healthy tissue.

"This new equipment has enabled us to improve the quality of our treatments while reducing waiting lists. Our waiting times have reduced from five weeks to three weeks, although we've achieved this with a heavy workload on our machines."

This workload increased shortly after the new machine arrived, when an older device at the only other Estonian radiotherapy hospital broke down and all that hospital's patients were transferred to the North Estonian Regional Hospital. "At present we are the only hospital in the country treating patients with a linear accelerator and we are extremely busy," said Maire Kuddu, chief radiation oncologist. Staff at the hospital are working double-shift on both machines as they attempt to cope with more than 130 patients a day.

Despite this heavy workload, the team has been able to introduce advanced IMRT for head and neck cancer patients. Intensity modulated radiotherapy enables clinicians to 'sculpt' the dose to the shape of the tumor and avoid more surrounding healthy tissue. For head and neck patients, it means more precise treatments and less potential harm to nearby salivary and parotid glands.

The new device was funded by the hospital with support from the International Atomic Energy Agency, which provided additional financing and helped to train staff in the use of the equipment, and the Environmental Investment Centre, which helped to decommission an older Cobalt-based treatment unit and refurbish the bunker for the new accelerator.

"We are delighted to be able to double both our own and the country's linear accelerator treatment capacity and introduce advanced radiotherapy techniques at the same time," adds Maire Kuddu. She said the hospital's future plans include equipping the new machine with an On-Board Imager(R) and introducing Varian's RapidArc(TM) capability for fast and precise image-guided IMRT.

"It is recognised that this is a major improvement in the country's cancer treatment capabilities but this is just a start," added Eduard Gerskevitch. "The number of treatment units is still very low compared with our needs and we will need to see further investment in radiotherapy in the future."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc. (NYSE: VAR), of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers Zero In on GI Cancers
2. Medical Experts Call for Obama Administration, Congress to Boost Funding for Prostate Cancer Imaging Research
3. Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers
4. NCC and Wyeth Donation to Assist Cancer Patients in Latin America
5. Researchers identify new protein that triggers breast cancer
6. U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer
7. NCCN and SEHA Collaborate to Improve Cancer Care
8. Multiple Screening Strategy Boosts Cervical Cancer Detection
9. Ovary Removal Lowers Odds of Cancer in High-Risk Women
10. Colonoscopy Quality Critical Factor to Thorough Exam and Best Colon Cancer Detection
11. The PA Breast Cancer Coalition Urges You to Donate Your State Income Tax Refund to Breast and Cervical Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: